S |
|
2020-10-08 17:28:24.0 |
ORAGENICS INC |
OGEN |
0.4% |
view |
B |
|
2020-08-13 16:43:32.0 |
PRECIGEN |
PGEN |
48.7% |
view |
S |
|
2020-08-13 16:27:05.0 |
AquaBounty Technologies |
AQB |
42.3% |
view |
B |
|
2020-03-02 17:05:17.0 |
ORAGENICS INC |
OGEN |
86.4% |
view |
B |
|
2020-02-18 16:01:55.0 |
AquaBounty Technologies |
AQB |
86.4% |
view |
B |
|
2020-02-04 16:59:52.0 |
PRECIGEN |
PGEN |
48.2% |
view |
S |
|
2020-01-06 16:01:16.0 |
INTREXON CORP |
XON |
n/a |
view |
B |
|
2019-11-05 16:53:10.0 |
HALOZYME THERAPEUTICS |
HALO |
4.8% |
view |
B |
|
2019-10-31 07:47:08.0 |
AquaBounty Technologies |
AQB |
86.4% |
view |
S |
|
2019-09-17 16:33:47.0 |
Fibrocell Science |
FCSC |
n/a |
view |
S |
|
2019-07-03 16:01:22.0 |
HALOZYME THERAPEUTICS INC |
HALO |
2.59% |
view |
B |
|
2019-06-10 17:24:57.0 |
INTREXON CORP |
XON |
2.59% |
view |
B |
|
2019-06-07 17:10:09.0 |
HALOZYME THERAPEUTICS INC |
HALO |
8.3% |
view |
B |
|
2019-05-24 19:35:46.0 |
INTREXON CORP |
XON |
2.59% |
view |
B |
|
2019-05-15 17:30:39.0 |
INTREXON CORP |
XON |
2.59% |
view |
S |
|
2019-04-03 17:13:46.0 |
Synthetic Biologics |
SYN |
2.59% |
view |
S |
|
2019-01-15 17:23:06.0 |
HISTOGENICS CORP |
HSGX |
2.59% |
view |
B |
|
2018-12-12 15:50:33.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
2.59% |
view |
S |
|
2018-10-29 16:31:16.0 |
AquaBounty Technologies |
AQB |
2.59% |
view |
S |
|
2018-10-15 16:38:02.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
n/a |
view |
S |
|
2018-09-14 16:08:33.0 |
Precipio |
PRPO |
4.8% |
view |
B |
|
2018-08-28 17:23:45.0 |
HALOZYME THERAPEUTICS INC |
HALO |
2.59% |
view |
B |
|
2018-08-16 17:19:23.0 |
HALOZYME THERAPEUTICS INC |
HALO |
2.59% |
view |
B |
|
2018-07-06 16:44:41.0 |
INTREXON CORP |
XON |
2.59% |
view |
S |
|
2018-01-22 09:20:24.0 |
INTREXON CORP |
XON |
2.59% |
view |
B |
|
2018-01-19 16:34:22.0 |
AquaBounty Technologies |
AQB |
64.3% |
view |
B |
|
2018-01-02 08:57:30.0 |
INTREXON CORP |
XON |
47.4% |
view |
B |
|
2017-12-13 16:59:07.0 |
Fibrocell Science |
FCSC |
43.7% |
view |
S |
|
2017-11-13 17:08:48.0 |
ORAGENICS INC |
OGEN |
n/a |
view |
S |
|
2017-10-23 17:01:42.0 |
INTREXON CORP |
XON |
n/a |
view |
S |
|
2017-09-05 17:26:05.0 |
Precipio |
TBIO |
15.6% |
view |
S |
|
2017-07-26 17:24:56.0 |
INTREXON CORP |
XON |
46.7% |
view |
S |
|
2017-07-26 17:24:41.0 |
HALOZYME THERAPEUTICS INC |
HALO |
2.59% |
view |
B |
|
2017-07-26 17:23:54.0 |
AquaBounty Technologies |
AQB |
2.59% |
view |
S |
|
2017-07-03 17:14:56.0 |
Precipio |
TBIO |
16.3% |
view |
S |
|
2017-06-16 17:24:59.0 |
SOLIGENIX |
SNGX |
4.9% |
view |
B |
|
2017-06-12 17:17:37.0 |
TRANSGENOMIC INC |
TBIO |
22.1% |
view |
B |
|
2017-05-26 17:13:02.0 |
SOLIGENIX |
SNGX |
6.3% |
view |
S |
|
2017-05-18 17:00:46.0 |
SOLIGENIX |
SNGX |
2.59% |
view |
S |
|
2017-05-08 17:28:05.0 |
SOLIGENIX |
SNGX |
9.3% |
view |
S |
|
2017-04-11 16:31:30.0 |
TRANSGENOMIC INC |
TBIO |
n/a |
view |
B |
|
2017-03-10 15:43:37.0 |
Fibrocell Science |
FCSC |
n/a |
view |
B |
|
2017-01-20 17:01:00.0 |
AquaBounty Technologies |
AQB |
2.59% |
view |
B |
|
2016-12-30 16:03:28.0 |
AmpliPhi Biosciences Corp |
APHB |
1.06% |
view |
B |
|
2016-11-16 17:24:19.0 |
AmpliPhi Biosciences Corp |
APHB |
n/a |
view |
S |
|
2016-09-09 16:09:18.0 |
Fibrocell Science |
FCSC |
n/a |
view |
S |
|
2016-06-02 16:40:42.0 |
INTREXON CORP |
XON |
52.3% |
view |
S |
|
2016-06-02 16:36:52.0 |
HALOZYME THERAPEUTICS INC |
HALO |
15.0% |
view |
S |
|
2016-04-15 15:49:47.0 |
AmpliPhi Biosciences Corp |
APHB |
n/a |
view |
S |
|
2016-01-12 16:42:37.0 |
TRANSGENOMIC INC |
TBIO |
35.6% |
view |
B |
|
2015-12-03 16:28:28.0 |
ORAGENICS INC |
OGEN |
33.2% |
view |
B |
|
2015-09-04 14:37:54.0 |
Synthetic Biologics |
SYN |
14.6% |
view |
S |
|
2015-07-27 16:28:42.0 |
Fibrocell Science |
FCSC |
2.59% |
view |
B |
|
2015-06-08 21:26:02.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
7.6% |
view |
B |
|
2015-03-20 16:21:28.0 |
AmpliPhi Biosciences Corp |
APHB |
2.59% |
view |
B |
|
2015-02-13 14:30:24.0 |
AmpliPhi Biosciences Corp |
TGEN |
2.05% |
view |
S |
|
2015-02-10 14:55:31.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
2.59% |
view |
S |
|
2015-01-05 17:25:34.0 |
INTREXON CORP |
XON |
60.9% |
view |
B |
|
2014-12-10 17:04:29.0 |
HISTOGENICS CORP |
HSGX |
21.1% |
view |
B |
86.71% |
2014-04-07 17:24:32.0 |
INTREXON CORP |
XON |
63.4% |
view |
B |
-70.70% |
2014-03-07 16:58:51.0 |
TRANSGENOMIC INC |
TBIO |
37.2% |
view |
B |
-27.31% |
2014-01-28 12:23:54.0 |
Fibrocell Science |
FCSC |
37.3% |
view |
B |
0.79% |
2013-12-30 16:07:33.0 |
MEDISTEM INC |
MEDS |
83.6% |
view |
S |
|
2013-12-26 14:33:16.0 |
ORAGENICS INC |
OGEN |
4.0% |
view |
S |
|
2013-12-19 16:55:45.0 |
Synthetic Biologics |
SYN |
5.0% |
view |
B |
-60.00% |
2013-11-22 16:13:17.0 |
ORAGENICS INC |
OGEN |
26.2% |
view |
B |
-13.31% |
2013-10-31 15:10:54.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
18.2% |
view |
S |
|
2013-10-03 12:40:26.0 |
Fibrocell Science |
FCSC |
36.9% |
view |
B |
-59.15% |
2013-10-02 16:52:33.0 |
ORAGENICS INC |
OGEN |
26.2% |
view |
B |
-37.25% |
2013-07-30 17:01:53.0 |
Fibrocell Science |
FCSC |
38.4% |
view |
B |
114.00% |
2013-06-26 12:25:02.0 |
SOLIGENIX |
SNGX |
31.9% |
view |
B |
35.25% |
2013-05-09 17:01:27.0 |
SOLIGENIX |
SNGX |
8.5% |
view |
B |
|
2013-01-31 17:09:21.0 |
TRANSGENOMIC INC |
TBIO |
27.0% |
view |
B |
-33.90% |
2012-11-09 15:41:57.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
17.9% |
view |
B |
-35.90% |
2012-11-01 17:01:04.0 |
Synthetic Biologics |
SYN |
22.5% |
view |
B |
|
2012-10-19 16:27:17.0 |
Synthetic Biologics |
AEN |
20.0% |
view |
B |
1,857.89% |
2012-10-15 14:22:02.0 |
Fibrocell Science |
FCSC |
35.3% |
view |
S |
|
2012-08-03 17:19:41.0 |
ORAGENICS INC |
ORNI |
19.5% |
view |
B |
|
2012-06-12 17:00:28.0 |
ORAGENICS INC |
ORNI |
26.5% |
view |
B |
-24.46% |
2012-06-06 16:30:54.0 |
HALOZYME THERAPEUTICS INC |
HALO |
17.7% |
view |
B |
-45.02% |
2012-02-13 17:24:37.0 |
HALOZYME THERAPEUTICS INC |
HALO |
16.8% |
view |
S |
|
2012-02-07 17:17:39.0 |
TRANSGENOMIC INC |
TBIO |
22.9% |
view |
B |
-20.59% |
2012-01-25 15:44:38.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
14.5% |
view |
B |
|
2011-12-12 17:26:05.0 |
ADEONA PHARMACEUTICALS |
AEN |
10.0% |
view |
S |
|
2011-08-17 17:10:14.0 |
HALOZYME THERAPEUTICS INC |
HALO |
15.8% |
view |
B |
1.37% |
2011-08-16 17:26:04.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
12.9% |
view |
S |
|
2011-03-01 17:03:03.0 |
CLINICAL DATA INC |
CLDA |
51.2% |
view |
B |
-8.49% |
2011-02-11 17:06:55.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
12.2% |
view |
B |
-6.17% |
2011-01-20 16:38:20.0 |
ZIOPHARM ONCOLOGY INC |
ZIOP |
11.1% |
view |
B |
69.44% |
2011-01-10 20:06:44.0 |
TRANSGENOMIC INC |
TBIO |
24.0% |
view |
B |
9.47% |
2009-09-22 10:54:33.0 |
CLINICAL DATA INC |
CLDA |
62.5% |
view |
B |
117.72% |
2009-02-27 17:00:09.0 |
CLINICAL DATA INC |
CLDA |
60.3% |
view |
B |
2.92% |
2008-09-30 17:02:39.0 |
CLINICAL DATA INC |
CLDA |
48.4% |
view |
B |
19.73% |
2008-07-01 17:33:17.0 |
HALOZYME THERAPEUTICS INC |
HALO |
19.1% |
view |
B |
-25.74% |
2008-03-24 16:52:10.0 |
HALOZYME THERAPEUTICS INC |
HALO |
17.7% |
view |
S |
|
2007-07-20 14:48:12.0 |
CLINICAL DATA INC |
CLDA |
5.6% |
view |
B |
-50.09% |
2007-06-05 15:07:50.0 |
HALOZYME THERAPEUTICS INC |
HALO |
14.6% |
view |
B |
-50.97% |
2007-05-24 16:27:12.0 |
HALOZYME THERAPEUTICS INC |
HALO |
10.5% |
view |
B |
51.04% |
2007-02-27 17:26:01.0 |
CLINICAL DATA INC |
CLDA |
7.5% |
view |
B |
|
2007-02-23 14:51:07.0 |
NEW RIVER PHARMACEUTICALS INC |
NRPH |
50.2% |
view |
S |
|
2007-02-14 09:24:49.0 |
NEW RIVER PHARMACEUTICALS INC |
NRPH |
15.6% |
view |
S |
|
2006-09-22 17:23:41.0 |
CLINICAL DATA INC |
CLDA |
7.1% |
view |
B |
|
2006-08-18 10:46:14.0 |
HALOZYME THERAPEUTICS INC |
HTI |
10.22% |
view |
S |
|
2006-06-15 00:00:00.0 |
CLINICAL DATA INC |
CLDA |
40.4% |
view |
S |
|
2006-05-23 00:00:00.0 |
CLINICAL DATA INC |
CLDA |
41.0% |
view |
B |
|
2006-03-03 00:00:00.0 |
HALOZYME THERAPEUTICS INC |
HZYM |
9.22% |
view |
S |
|
2006-02-16 00:00:00.0 |
NEW RIVER PHARMACEUTICALS INC |
NRPH |
17.5% |
view |
B |
-25.24% |
2006-02-15 00:00:00.0 |
CLINICAL DATA INC |
CLDA |
43.2% |
view |
S |
|
2005-11-23 00:00:00.0 |
CLINICAL DATA INC |
CLDA |
41.9% |
view |
B |
-14.47% |
2005-06-27 00:00:00.0 |
CLINICAL DATA INC |
CLDA |
62.7% |
view |
B |
-1.55% |
2005-06-24 00:00:00.0 |
NEW RIVER PHARMACEUTICALS INC |
NRPH |
63.4% |
view |
B |
-46.15% |
2004-02-24 00:00:00.0 |
SCICLONE PHARMACEUTICALS INC |
SCLN |
4.6% |
view |
B |
57.88% |
2003-11-14 00:00:00.0 |
CLINICAL DATA INC |
CLDA |
59.5% |
view |
B |
183.01% |
2003-05-02 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
39.7% |
view |
S |
|
2002-10-02 00:00:00.0 |
SCICLONE PHARMACEUTICALS INC |
SCLN |
2.0% |
view |
S |
|
2002-08-21 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
39.5% |
view |
B |
210.16% |
2002-06-12 00:00:00.0 |
SCICLONE PHARMACEUTICALS INC |
SCLN |
8.1% |
view |
B |
-47.36% |
2001-10-30 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
40.4% |
view |
B |
-55.33% |
2001-10-26 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
37.0% |
view |
B |
-41.42% |
2001-09-07 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
34.6% |
view |
B |
19.23% |
2001-06-26 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
32.9% |
view |
B |
79.00% |
2001-06-08 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
30.9% |
view |
B |
0.21% |
2001-04-12 00:00:00.0 |
SCICLONE PHARMACEUTICALS INC |
SCLN |
6.2% |
view |
B |
86.29% |
2001-03-01 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
29.5% |
view |
S |
|
2001-01-08 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
27.8% |
view |
B |
39.37% |
2000-06-09 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
27.8% |
view |
S |
|
2000-05-02 00:00:00.0 |
HEMAGEN DIAGNOSTICS INC |
HMGN |
0.0% |
view |
B |
6.21% |
2000-03-15 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
27.3% |
view |
B |
6.21% |
2000-03-15 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
27.3% |
view |
B |
-44.57% |
2000-02-14 00:00:00.0 |
HEMAGEN DIAGNOSTICS INC |
HMGN |
6.45% |
view |
B |
-29.45% |
1999-12-06 00:00:00.0 |
NOVITRON INTERNATIONAL INC |
CLDA |
25.8% |
view |